We explored how vitamin D3, coupled with antioxidant supplements, can help prevent recurrent cases of benign paroxysmal positional vertigo (BPPV), a common type of dizziness. In this multicentric trial involving 128 patients who experienced frequent episodes of BPPV, we organized participants into three groups based on their vitamin D levels and treatment.
The first group received vitamin D3 along with a combination of alpha-lipoic acid, Carnosine, and Zinc, as well as vitamins from the B group. The second group, with sufficient vitamin D but no supplementation, served as a control. Meanwhile, the third group had sufficient vitamin D and received a different antioxidant mix.
After a six-month follow-up, we observed a significant reduction in dizziness relapses only among those in the first group who had insufficient or deficient vitamin D levels prior to treatment. Unfortunately, the other groups did not show similar improvements. This highlights the importance of addressing vitamin D deficiency, especially for those prone to recurrent dizziness. However, we must be cautious, as the combination of different supplements makes it challenging to isolate the effects solely attributed to vitamin D3.